Poly Medicure Limited

Yield per half year: -26.11%
Dividend yield: 0.1448%
Sector: Healthcare

Poly Medicure Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
2/10
55.75 101.26 -44.94% 57.57 -3.15%
P/S 11.3 13.09 -13.62%
P/BV 6.82 6.58 3.8%
P/FCF -208.32 31.47 -761.89%
Ev/Ebitda 49.35 16.9 191.98%
Ev/S 13.36 10.1 32.25%
Ev/FCF -246.25 32.61 -855.15%
E/P 0.0179 0.0314 -43.01%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
27.08 -6.64 -507.65% 26.91 +0.6247%
ROE 12.24 15.84 -22.72%
ROA 10.6 7.66 38.42%
ROIC 17.55 15.5 13.21%
ROS 20.27 -15.15 -233.8%
ROCE 13.44 17.75 -24.26%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.3987 1.13 -64.84% 0.5056 -21.15%
Nеt Debt/Ebitda 0.0639 0.3504 -81.76%
Debt/Ratio 0.0565 0.1597 -64.65%
Debt/Equity 0.1543 0.6505 -76.28%
Debt/Net Income 0.5324 28.22 -98.11%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0.35/10
0.1448 0.6029 -75.98% 0.2008 -27.9%
Number of years of dividend growth 1 1.26 -20.83%
DSI 1 0.8357 19.65%
Average dividend growth 8.49 -68.14 -112.46%
Average percentage for 5 years 0.2008 5.8 -96.54%
Average percentage for payments 19.12 24.02 -20.4%
Difference from average difference in sector -0.4581

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
115.45 206.21 -44.01%
Growth impulse Ebitda in 5 years 94.91 230.99 -58.91%
Growth impulse Net Income in 5 years 149.17 217.1 -31.29%
Growth impulse FCF in 5 years -483.91 151.51 -419.39%
Growth impulse EPS in 5 years 123.84 228.35 -45.77%
IP Score
5.94/10

Similar companies

Apollo Hospitals Enterprise Limited

Dr. Reddy's Laboratories Limited

Sun Pharmaceutical Industries Limited

Cipla Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription